EDGE*TEST relies on Edge technology and our proprietary platform to statistically differentiate between diseased and healthy (or control and treated) tissue and cell samples. EDGE*TEST distinguishes between diseased and healthy samples by identifying a pair of defined density fractions whose biomarker content varies inversely in diseased versus healthy states. The ratio of relative marker content in these fractions can be directly correlated with diseased or healthy samples.

The EDGE*TEST method has been shown to be applicable to a broad range of diseases and dysfunctions with significant benefits:

• Rapid characterization of differences between diseased and healthy tissue
• Identification and evaluation of predictive, diagnostic and prognostic disease biomarkers
• The method is INDEPENDENT of sample amount
• The method DOES NOT require internal or external standards
• Each sample is analyzed in its ENTIRETY for a defined marker